Use of etiotropic and pathogenetic medicines for COVID-19 in patients with renal failure and/or on dialysis

Rok vydání:	2020
Předmět:	medicine.medical_specialty Coronavirus disease 2019 (COVID-19) Pharmacokinetics Dose adjustment business.industry medicine.medical_treatment Urology medicine Renal function business Dialysis Renal drug
Zdroj:	Kachestvennaya klinicheskaya praktika. :39-46
ISSN:	2618-8473 2588-0519
DOI:	10.37489/2588-0519-2020-s4-39-46
Popis:	Impaired kidney function may influence pharmacokinetics of most of the drugs, including the ones used in COVID-19. In this publication, the most important pharmacokinetic parameters and dose adjustment approaches are provided, based on The Renal Drug Handbook и Sanford Guide. In the majority of cases, mild kidney function reduction does not necessitate dose adjustment. Each case should be considered individually, measuring benefits against risks.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::928b5694f7a231d0a0df65322dca4d02 https://doi.org/10.37489/2588-0519-2020-s4-39-46 Zobrazit plný text záznamu